This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Five Mid-Cap Stocks That Are Beating Indices

4. Bio-Reference Laboratories (BRLI - Get Report) provides clinical-testing services in the New York metropolitan area.

The numbers: Fiscal fourth-quarter net income increased 37% to $7.2 million, and earnings per share rose 34% to 51 cents. Revenue advanced 26% to $102 million. Bio-Reference's operating margin ascended from 12% to 13%. The company has a stable financial position, with a quick ratio of 1.9 and a debt-to-equity ratio of 0.2.

The stock: Bio-Reference Laboratories increased 52% during the past year, outpacing major U.S. indices. The stock trades at a price-to-earnings ratio of 24, a premium to health-care-service peers. Bio-Reference doesn't pay dividends.

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
BCPC $52.63 0.00%
BRLI $33.16 0.00%
CHD $81.93 0.00%
CHKP $83.95 0.00%
EW $127.19 0.00%

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs